![](/img/cover-not-exists.png)
Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer
Sasaki, Akinori, Nakamura, Yoshiaki, Mishima, Saori, Kawazoe, Akihito, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Doi, Toshihiko, Ohtsu, Atsushi, Yoshino, Takayuki, Kuwata, Takeshi, Akimoto,Language:
english
Journal:
Gastric Cancer
DOI:
10.1007/s10120-018-00922-8
Date:
January, 2019
File:
PDF, 1.03 MB
english, 2019